Omega-3 fatty acids in smooth muscle cell phospholipids increase membrane cholesterol efflux.
The aim of our work was to determine whether fatty acid modifications in smooth muscle cell phospholipids affect cholesterol efflux and desorption. [3H]Cholesterol was used to label cholesterol pools in the whole cell or selectively in the plasma membrane. Cells were incubated for 12 h in order to increase oleate, linoleate, arachidonate, eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) in phospholipids. Cholesterol efflux was monitored using native or tetranitromethane modified high-density lipoprotein3 (HDL3). When all cholesterol pools were labeled, the efflux from cells treated with different fatty acids were not different. Plasma membrane cholesterol efflux remained unchanged after oleate, linoleate or arachidonate treatments, but was markedly increased after EPA and DHA enrichment, both with native HDL3 and with tetranitromethane-high-density lipoprotein. These results suggest that the positive effects of n-3 fatty acid consumption on the atherosclerotic process could be linked in part to an increase in plasma membrane cholesterol efflux from vascular smooth muscle cells.
Dusserre
E
E
National Institute of Health and Medical Research, INSERM U63, Bron-Lyon, France.
Pulcini
T
T
Bourdillon
M C
MC
Ciavatti
M
M
Berthezene
F
F
D000818:Animals; D002478:Cells, Cultured; D002784:Cholesterol / Q000378:metabolism*; D005230:Fatty Acids, Nonesterified / Q000494:pharmacology; D015525:Fatty Acids, Omega-3 / Q000032:analysis*; D008563:Membrane Lipids / Q000502:physiology*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology*; D010743:Phospholipids / Q000737:chemistry*; D051381:Rats
D005230:Fatty Acids, Nonesterified; D015525:Fatty Acids, Omega-3; D008563:Membrane Lipids; D010743:Phospholipids; D002784:Cholesterol